These variants underlie two related conditions: PLCG2-associated antibody deficiency and immune dysregulation (PLAID, OMIM 614468) and its autoinflammatory counterpart APLAID (OMIM 614878). The gene discussed is PLCG2; the disease is agammaglobulinemia.